- Raised $2.8M funding round, Aug 2018
- Raised $2.2M funding round, Jul 2013
- Raised $1.5M funding round, Apr 2012
About
Insuline Medical is focused on improving the performance of current insulin treatment methods by better utilizing human physiology. Its flagship product, the InsuPad, is composed of a disposable injection window (Fenster) and a reusable, rechargeable control unit using skin-condition stabilization technology. By gently warming the skin, the device increases blood flow, helping the body absorb insulin more quickly and effectively. InsuPad is noninvasive, safe, simple, easy to use, and has Medical Device Directive (CE mark) approval for the European Union. Insuline's InsuPad offers significant clinical benefits to patients, physicians, and health insurance providers. Insuline Medical has initiated commercialization in Germany in collaboration with J&J (LifeScan) and in Israel with DYN diagnostics, exclusive representatives of Roche Diagnostics in Israel.
Funding history · 3 rounds · $6.5M total
Q&A
- What is InsuLine Medical's primary product?
- InsuLine Medical's flagship product is the InsuPad, a device designed to improve insulin absorption by gently warming the skin to increase blood flow. It consists of a disposable injection window and a reusable control unit.
- When was InsuLine Medical founded?
- InsuLine Medical was founded in February 2007.
- What is the current status of InsuLine Medical?
- InsuLine Medical is currently inactive and ceased to operate in June 2019.
- How much total funding has InsuLine Medical raised?
- InsuLine Medical has raised a total of $6,500,000 USD across its funding rounds.
- When was InsuLine Medical's last funding round and who invested?
- InsuLine Medical's last funding round was in August 2018, with IBI Investment House participating.
- Which investors participated in InsuLine Medical's April 2012 funding round?
- Pontifax participated in InsuLine Medical's funding round in April 2012.
- In which countries did InsuLine Medical initiate commercialization of its InsuPad product?
- InsuLine Medical initiated commercialization of the InsuPad in Germany, in collaboration with J&J (LifeScan), and in Israel, with DYN diagnostics.
- What is InsuLine Medical's employee count?
- InsuLine Medical has an employee count in the 1-10 range.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/1461439 | |
| YouTube | youtube.com/channel/UC7SawJxDF5S9CSaIjnuA-wA |
Identifiers & details
| Founded | 2007-2 |
|---|---|
| Employees (exact) | 4 |
| Status reason | Non Active, Jun 2019 ceased to operate |